Factor VIII inhibitor bypass activity Other names: FEIBA

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code	Group title	Classification
B02BD03	Factor VIII inhibitor bypassing activity	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD03

Medicines

Factor VIII inhibitor bypass activity is an active ingredient of these brands:

Austria (AT)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Brazil (BR)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Canada (CA)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Croatia (HR)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Ecuador (EC)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Estonia (EE)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Finland (FI)

(combination) FEIBA as Factor VIII inhibitor bypass activity

France (FR)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Hong Kong (HK)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Ireland (IE)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Israel (IL)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Japan (JP)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Lithuania (LT)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Malta (MT)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Netherlands (NL)

(combination) FEIBA as Factor VIII inhibitor bypass activity

New Zealand (NZ)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Poland (PL)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Romania (RO)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Singapore (SG)

(combination) FEIBA as Factor VIII inhibitor bypass activity

South Africa (ZA)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Spain (ES)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Tunisia (TN)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Turkey (TR)

(combination) FEIBA as Factor VIII inhibitor bypass activity

United Kingdom (UK)

(combination) FEIBA as Factor VIII inhibitor bypass activity

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.